| Literature DB >> 30862209 |
Gabriel Lopez1, Carol Eddy1, Wenli Liu1, Yisheng Li2, Minxing Chen2, Eduardo Bruera1, Lorenzo Cohen1.
Abstract
BACKGROUND: Exercise - contributes to improved treatment-related outcomes. We reviewed characteristics of cancer patients referred for physical therapist-led exercise counseling at a comprehensive cancer center and its effects on self-reported symptoms and quality of life.Entities:
Keywords: cancer; complementary health approaches; exercise counseling; integrative oncology; patient reported outcomes; physical therapy
Mesh:
Year: 2019 PMID: 30862209 PMCID: PMC6416745 DOI: 10.1177/1534735419832360
Source DB: PubMed Journal: Integr Cancer Ther ISSN: 1534-7354 Impact factor: 3.279
Patient Demographics and Clinical Characteristics (n = 350).
| Characteristics | n (%)[ | |
|---|---|---|
| Age | Mean (SD) = 55.83 (12.76) | |
| Gender | Female | 272 (77.7%) |
| Male | 78 (22.3%) | |
| Race | White or Caucasian | 232 (66.3%) |
| Hispanic | 50 (14.3%) | |
| Asian | 29 (8.3%) | |
| Black or African American | 26 (7.4%) | |
| Other/Not specified | 13 (3.7%) | |
| Marital status | Married/Significant other | 247 (70.6%) |
| Single | 47 (13.4%) | |
| Divorced/Legally separated | 33 (9.4%) | |
| Widowed | 22 (6.3%) | |
| Other | 1 (0.3%) | |
| Residence | Harris Country | 110 (31.4%) |
| Seven surrounding counties | 53 (15.1%) | |
| Rest of Texas | 162 (46.3%) | |
| Rest of the United States | 13 (3.7%) | |
| International | 12 (3.4%) | |
| Cancer | Breast | 152 (43.4%) |
| Gastrointestinal | 57 (16.3%) | |
| Thoracic/Head and neck | 34 (9.7%) | |
| Gynecological | 25 (7.1%) | |
| Genitourinary | 21 (6.0%) | |
| Lymphoma/Myeloma | 20 (5.7%) | |
| Sarcoma | 11 (3.1%) | |
| Leukemia | 9 (2.6%) | |
| Central nervous system | 8 (2.2%) | |
| Melanoma | 7 (2.0%) | |
| Endocrine glands | 5 (1.4%) | |
| Other | 1 (0.3%) | |
| Stage | Advanced | 70 (20.0%) |
| Local | 108 (30.9%) | |
| Unstaged | 172 (49.1%) |
Unless otherwise mentioned.
Summary Statistics With Paired t-Test Results for the Change in Pre/Post ESAS Symptoms and Subscales for Those Who Have a Symptom Score at Baseline of 1 or Greater.
| ESAS Symptoms and Subscales | Baseline Difference Between
Pre/Post Values | ||||
|---|---|---|---|---|---|
| n | Mean, Pre-exercise | Mean, Postexercise | Mean Change (SD)[ | ||
| Pain | 179 | 3.46 | 2.93 | −0.54 (1.55) | <.001 |
| Fatigue | 218 | 3.85 | 3.04 | −0.81 (1.99) | <.001 |
| Nausea | 62 | 2.77 | 1.79 | −0.98 (1.55) | <.001 |
| Depression | 124 | 3.1 | 2.48 | −0.62 (1.38) | <.001 |
| Anxiety | 164 | 3.34 | 2.41 | −0.93 (1.54) | <.001 |
| Drowsiness | 141 | 3.27 | 2.72 | −0.55 (1.54) | <.001 |
| Appetite | 170 | 3.99 | 3.26 | −0.73 (1.95) | <.001 |
| Wellbeing | 227 | 3.82 | 2.96 | −0.86 (1.55) | <.001 |
| Shortness of breath | 83 | 2.75 | 2.13 | −0.61 (1.52) | <.001 |
| Sleep | 230 | 4.21 | 3.7 | −0.51 (1.57) | <.001 |
| Financial distress | 156 | 4.01 | 3.5 | −0.51 (1.4) | <.001 |
| Spiritual pain | 92 | 2.89 | 2.17 | −0.72 (1.36) | <.001 |
| GDS[ | 252 | 18.52 | 15.2 | −3.32 (6.52) | <.001 |
| PHS[ | 249 | 11.7 | 9.82 | −1.89 (4.81) | <.001 |
| PSS[ | 175 | 5.33 | 4.08 | −1.25 (2.3) | <.001 |
For all symptoms, a change in score of ≥1 is considered clinically significant. For predetermined subscales, clinical significance is defined as follows: ≥3 for global distress score (GDS); ≥2 for physical distress score (PHS) and psychological distress score (PSS).
GDS equals sum of pain, fatigue, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath (total score 0-90); PHS equals sum of pain, fatigue, nausea, drowsiness, appetite, and shortness of breath (total 0-60); and PSS equals sum of depression and anxiety.
Paired t-Test Results for ESAS Scores at Baseline and First Follow-up Within 60 Days.
| ESAS Symptoms and Subscales | n | Baseline, Mean (SD) | First Follow-up Within 60 Days, Mean (SD) | Mean Change (SD)[ | |
|---|---|---|---|---|---|
| Pain | 37 | 3.03 (2.42) | 2.57 (2.21) | −0.46 (2.27) | .23 |
| Fatigue | 37 | 3.97 (2.71) | 2.76 (2.02) | −1.22 (2.75) | . |
| Nausea | 37 | 0.51 (1.15) | 0.54 (1.41) | 0.03 (1.82) | .93 |
| Depression | 37 | 2.62 (3.04) | 1.78 (2.44) | −0.84 (2.48) | . |
| Anxiety | 37 | 2.51 (2.73) | 2.27 (2.55) | −0.24 (1.59) | .36 |
| Drowsiness | 37 | 1.43 (1.83) | 1.08 (1.46) | −0.35 (1.65) | .20 |
| Appetite | 37 | 3.14 (2.53) | 2.16 (2.06) | −0.97 (2.47) | . |
| Well-being | 37 | 3.68 (2.54) | 3.03 (2.09) | −0.65 (2.38) | .11 |
| Shortness of breath | 37 | 1.03 (1.96) | 0.92 (1.66) | −0.11 (1.15) | .57 |
| Sleep | 37 | 3.65 (2.46) | 3.08 (2.47) | −0.57 (1.82) | .07 |
| Financial distress | 37 | 2.59 (2.99) | 2.11 (2.59) | −0.49 (1.92) | .13 |
| Spiritual pain | 37 | 1.38 (2.37) | 1.19 (2.25) | −0.19 (1.27) | .37 |
| GDS[ | 37 | 21.92 (12.57) | 17.11 (12.4) | −4.81 (10.16) | . |
| PHS[ | 37 | 13.11 (7.35) | 10.03 (7.3) | −3.08 (7.98) | . |
| PSS[ | 37 | 5.14 (5.66) | 4.05 (4.65) | −1.08 (3.68) | .08 |
For all symptoms, a change score of ≥1 is considered clinically significant. For predetermined subscales, clinical significance is defined as follows: ≥3 for the global distress score (GDS); ≥2 for physical distress score (PHS) and psychological distress score (PSS).
The P values less than .05 (in bold) suggest a statistically significant change between baseline and first follow-up within 60 days.
GDS equals the sum of pain, fatigue, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath (total score 0-90); PHS equals sum of pain, fatigue, nausea, drowsiness, appetite, and shortness of breath (total 0-60); and PSS equals sum of depression and anxiety.
Paired t-Test Results for PROMIS10 Scores at Baseline and First Follow-up Within 60 Days.
| PROMIS10 | n | Baseline, Mean (SD) | First Follow-up Within 60 Days, Mean (SD) | |
|---|---|---|---|---|
| Mental health subscale | 89 | 12.9 (3.1) | 13.6 (3.2) | . |
| Physical health subscale | 89 | 13.3 (2.9) | 13.8 (2.8) | . |
| Global total score | 89 | 32.4 (6.9) | 33.9 (7.1) | . |
Abbreviation: PROMIS10, Patient-Reported Outcomes Measurement Information System.
The P values less than .05 (in bold) suggest a significant change between baseline and first follow-up within 60 days.